RXL — ProShares Ultra Health Care
Data updated: 2026-08-14
RXL — ProShares Ultra Health Care. Leveraged · $72.08M AUM · 0.95% expense ratio · 21.4% 1-yr return. Holdings, fees, performance and SEC filings.
RXL Fund Overview
RXL — ProShares Ultra Health Care is a US ETF managed by Proshares Trust, categorised as Leveraged. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: Proshares Trust
- Category: Leveraged
- Assets under management: $72.08M
- 1-year return: 21.4%
- Ticker: RXL
- SEC CIK: 0001174610
- SEC series ID: S000014253
- Share class ID: C000038812
RXL Holdings
Top 10 holdings of ProShares Ultra Health Care by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Eli Lilly & Co. | 12.67% |
| ProShares GENIUS Money Market ETF | 11.81% |
| Johnson & Johnson | 7.86% |
| AbbVie, Inc. | 5.57% |
| UnitedHealth Group, Inc. | 4.98% |
| Merck & Co., Inc. | 4.26% |
| Repurchase Agreement | 2.91% |
| Thermo Fisher Scientific, Inc. | 2.68% |
| Amgen, Inc. | 2.62% |
| Gilead Sciences, Inc. | 2.41% |
RXL Portfolio Allocation
Asset-class allocation of ProShares Ultra Health Care by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 78.0% |
| Other | 11.8% |
| Cash & Equivalents | 7.1% |
RXL Performance
Total returns for RXL (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -8.8% |
| 1 year | 21.4% |
| 3 years (annualised) | 5.8% |
| 5 years (annualised) | 2.0% |
RXL Risk Information
Risk metrics for RXL, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 30.6%
RXL Costs and Fees
RXL costs about $95 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.95%
- Gross expense ratio: 1.05%
- Portfolio turnover: 4%
- Brokerage commissions: 0.12 bps of average net assets (SEC N-CEN)
RXL Cashflows
Over the 12 months to 2026-05, ProShares Ultra Health Care had net outflows of $3.92M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-05 | −$4.03M |
| 2026-04 | −$1.38M |
| 2026-03 | −$2.46M |
| 2026-02 | $0 |
| 2026-01 | $0 |
| 2025-12 | $5.08M |
RXL Debt Constituents
No individual debt constituents are reported in ProShares Ultra Health Care's latest SEC N-PORT filing.
RXL Prospectus and SEC Filings
Official ProShares Ultra Health Care filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2024-09-26
- Prospectus supplement (497) — filed 2025-04-07
- Prospectus supplement (497) — filed 2024-11-13
- Portfolio holdings (N-PORT) — filed 2026-07-28
- Portfolio holdings (N-PORT) — filed 2026-04-24
- Portfolio holdings (N-PORT) — filed 2026-01-28
- Annual census (N-CEN) — filed 2026-08-14
- Annual census (N-CEN) — filed 2025-08-13
Related Funds
Other Leveraged funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.